Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: Structure-activity relationship and mechanism of modulation

Journal of Medicinal Chemistry

Volumn 55, Issue 5, 2012, Pages 1999-2014

  Chan, Kin Fai ^a   Wong, Iris L K ^a   Kan, Jason W Y ^a   Yan, Clare S W ^a   Chow, Larry M C ^a   Chan, Tak Hang ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; DIMER; DOXORUBICIN; FLAVONOID; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CANCER CELL; CANCER RESISTANCE; COMPETITIVE INHIBITION; MULTIDRUG RESISTANCE; STRUCTURE ACTIVITY RELATION;

EID: 84858039954     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201121b     Document Type: Article

References (50)

1. Germann, U. A. P-glycoprotein: a mediator of multidrug resistance in tumour cells Eur. J. Cancer 1996, 32A, 927-944
2. Szakacs, G.; Paterson, J. K.; Ludwig, J. A.; Booth-Genthe, C.; Gottesman, M. M. Targeting multidrug resistance in cancer Nat. Rev. Drug Discovery 2006, 5, 219-234
3. Aller, S. G.; Yu, J.; Ward, A.; Weng, Y.; Chittaboina, S.; Zhuo, R.; Harrell, P. M.; Trinh, Y. T.; Zhang, Q.; Urbatsch, I. L.; Chang, G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding Science 2009, 323, 1718-1722
4. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 1981, 41, 1967-1972
5. Hollt, V.; Kouba, M.; Dietel, M.; Vogt, G. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein Biochem. Pharmacol. 1992, 43, 2601-2608
6. Tsuruo, T.; Iida, H.; Nojiri, M.; Tsukagoshi, S.; Sakurai, Y. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers Cancer Res. 1983, 43, 2905-2910
7. Ganapathi, R.; Grabowski, D.; Turinic, R.; Valenzuela, R. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells Eur. J. Cancer Clin. Oncol. 1984, 20, 799-806
8. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors Cancer Res. 1982, 42, 4730-4733
9. Beck, W. T.; Cirtain, M. C.; Glover, C. J.; Felsted, R. L.; Safa, A. R. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine Biochem. Biophys. Res. Commun. 1988, 153, 959-966
10. Tsuruo, T.; Iida, H.; Kitatani, Y.; Yokota, K.; Tsukagoshi, S.; Sakurai, Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells Cancer Res. 1984, 44, 4303-4307
11. Chao, N. J.; Aihara, M.; Blume, K. G.; Sikic, B. I. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow Exp. Hematol. 1990, 18, 1193-1198
12. Slater, L. M.; Sweet, P.; Stupecky, M.; Gupta, S. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro J. Clin. Invest. 1986, 77, 1405-1408
13. Slater, L. M.; Sweet, P.; Stupecky, M.; Wetzel, M. W.; Gupta, S. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma Br. J. Cancer 1986, 54, 235-238
14. Twentyman, P. R.; Fox, N. E.; White, D. J. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line Br. J. Cancer 1987, 56, 55-57
15. Solary, E.; Velay, I.; Chauffert, B.; Bidan, J. M.; Caillot, D.; Dumas, M.; Guy, H. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM Cancer 1991, 68, 1714-1719
16. Barnes, K. M.; Dickstein, B.; Cutler, G. B., Jr.; Fojo, T.; Bates, S. E. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells Biochemistry 1996, 35, 4820-4827
17. Gruol, D. J.; Zee, M. C.; Trotter, J.; Bourgeois, S. Reversal of multidrug resistance by RU 486 Cancer Res. 1994, 54, 3088-3091
18. Ueda, K.; Okamura, N.; Hirai, M.; Tanigawara, Y.; Saeki, T.; Kioka, N.; Komano, T.; Hori, R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone J. Biol. Chem. 1992, 267, 24248-24252
19. Pirker, R.; FitzGerald, D. J.; Raschack, M.; Frank, Z.; Willingham, M. C.; Pastan, I. Enhancement of the activity of immunotoxins by analogues of verapamil Cancer Res. 1989, 49, 4791-4795
20. Hofmann, J.; Wolf, A.; Spitaler, M.; Bock, G.; Drach, J.; Ludescher, C.; Grunicke, H. Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine J. Cancer Res. Clin. Oncol. 1992, 118, 361-366
21. Twentyman, P. R.; Bleehen, N. M. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin Eur. J. Cancer 1991, 27, 1639-1642
22. Erratum: Eur. J. Cancer 1992, 28, 616.
23. Germann, U. A.; Ford, P. J.; Shlyakhter, D.; Mason, V. S.; Harding, M. W. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP Anti-Cancer Drugs 1997, 8, 141-155
24. Germann, U. A.; Shlyakhter, D.; Mason, V. S.; Zelle, R. E.; Duffy, J. P.; Galullo, V.; Armistead, D. M.; Saunders, J. O.; Boger, J.; Harding, M. W. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro Anti-Cancer Drugs 1997, 8, 125-140
25. Krishna, R.; Mayer, L. D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur. J. Pharm. Sci. 2000, 11, 265-283
26. Thomas, H.; Coley, H. M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein Cancer Control 2003, 10, 159-165
27. Harborne, J. B. Nature, distribution and function of plant flavonoids Prog. Clin. Biol. Res. 1986, 213, 15-24
28. Castro, A. F.; Altenberg, G. A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein Biochem. Pharmacol. 1997, 53, 89-93
29. Chieli, E.; Romiti, N.; Cervelli, F.; Tongiani, R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes Life Sci. 1995, 57, 1741-1751
30. Comte, G.; Daskiewicz, J. B.; Bayet, C.; Conseil, G.; Viornery-Vanier, A.; Dumontet, C.; Di Pietro, A.; Barron, D. C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance J. Med. Chem. 2001, 44, 763-768
31. Critchfield, J. W.; Welsh, C. J.; Phang, J. M.; Yeh, G. C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism Biochem. Pharmacol. 1994, 48, 1437-1445
32. Jodoin, J.; Demeule, M.; Beliveau, R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols Biochim. Biophys. Acta 2002, 1542, 149-159
33. Scambia, G.; Ranelletti, F. O.; Panici, P. B.; De Vincenzo, R.; Bonanno, G.; Ferrandina, G.; Piantelli, M.; Bussa, S.; Rumi, C.; Cianfriglia, M.; Mancuso, S. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target Cancer Chemother. Pharmacol. 1994, 34, 459-464
34. Zhang, S.; Morris, M. E. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J. Pharmacol. Exp. Ther. 2003, 304, 1258-1267
35. Chan, K. F.; Zhao, Y.; Burkett, B. A.; Wong, I. L.; Chow, L. M.; Chan, T. H. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells J. Med. Chem. 2006, 49, 6742-6759
36. Chan, K. F.; Zhao, Y.; Chow, T. W.; Yan, C. S.; Ma, D. L.; Burkett, B. A.; Wong, I. L.; Chow, L. M.; Chan, T. H. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: structure-activity relationships ChemMedChem 2009, 4, 594-614
37. Wong, I. L.; Chan, K. F.; Tsang, K. H.; Lam, C. Y.; Zhao, Y.; Chan, T. H.; Chow, L. M. Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives J. Med. Chem. 2009, 52, 5311-5322
38. Wong, I. L.; Chan, K. F.; Burkett, B. A.; Zhao, Y.; Chai, Y.; Sun, H.; Chan, T. H.; Chow, L. M. Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in leishmania Antimicrob. Agents Chemother. 2007, 51, 930-940
39. Wong, I. L.; Chan, K. F.; Zhao, Y.; Chan, T. H.; Chow, L. M. Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania J. Antimicrob. Chemother. 2009, 63, 1179-1190
40. Leonessa, F.; Green, D.; Licht, T.; Wright, A.; Wingate-Legette, K.; Lippman, J.; Gottesman, M. M.; Clarke, R. MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer Br. J. Cancer 1996, 73, 154-161
41. Mistry, P.; Stewart, A. J.; Dangerfield, W.; Okiji, S.; Liddle, C.; Bootle, D.; Plumb, J. A.; Templeton, D.; Charlton, P. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576 Cancer Res. 2001, 61, 749-758
42. +-dependent transport mechanism of dipeptide and anionic beta-lactam antibiotic ceftibuten in rat intestinal brush-border membrane J. Pharmacol. Exp. Ther. 1999, 289, 66-71
43. Wang, E. J.; Casciano, C. N.; Clement, R. P.; Johnson, W. W. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence Biochim. Biophys. Acta 2000, 1481, 63-74
44. Burns, J. M.; Dairaghi, D. J.; Deitz, M.; Tsang, M.; Schall, T. J. Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics J. Biol. Chem. 2002, 277, 2785-2789
45. Ayesh, S.; Shao, Y. M.; Stein, W. D. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein Biochim. Biophys. Acta 1996, 1316, 8-18
46. Litman, T.; Zeuthen, T.; Skovsgaard, T.; Stein, W. D. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity Biochim. Biophys. Acta 1997, 1361, 169-176
47. Wang, Y.; Hao, D.; Stein, W. D.; Yang, L. A kinetic study of rhodamine123 pumping by P-glycoprotein Biochim. Biophys. Acta 2006, 1758, 1671-1676
48. Bordunov, A. V. H., P.C.; Bradshaw, J. S.; Dalley, N. K.; Kou, X.; Zhang, X. X.; Izatt, R. M. Synthesis of new pyridinoazacrown ethers containing aromatic and heteroaromatic proton ionizable substituents J. Org. Chem. 1995, 60, 6097-6102
49. Maeda, H. F., S.; Nakatsuji, Y.; Okahara, M. Intramolecular cyclization of N, N -di(oligooxyethylene)amines: a new synthesis of monoaza crown ethers Tetrahedron 1982, 38, 3359-3362
50. Zhang, P. Y.; Wong, I. L.; Yan, C. S.; Zhang, X. Y.; Jiang, T.; Chow, L. M.; Wan, S. B. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells J. Med. Chem. 2010, 53, 5108-5120